Legal Representation
Attorney
Ann Lamport Hammitte
USPTO Deadlines
Application History
25 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 14, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Dec 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Dec 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Nov 27, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Nov 8, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Nov 8, 2024 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
Aug 6, 2024 | PCGR | O | PETITION TO DIRECTOR GRANTED | Loading... |
Aug 6, 2024 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
Aug 2, 2024 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
May 22, 2024 | ISPO | Z | WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST | Loading... |
May 14, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 14, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 7, 2024 | TPDR | I | TEAS PETITION TO DIRECTOR RECEIVED | Loading... |
Apr 24, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 10, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 10, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 10, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Apr 10, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 10, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Dec 24, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Dec 24, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Dec 24, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Dec 19, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 16, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 28, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical products for the treatment of hematologic cancers; pharmaceuticals for treatment of a myelodysplastic syndrome; pharmaceuticals for treatment of acute myeloid leukemia, which is also known as acute myelogenous leukemia and acute nonlymphocytic leukemia
Classification
International Classes
005